LATS2 and astrocytoma (excluding glioblastoma): In 2006, Jiang et al. showed that the promoter hypermethylation frequencies of LATS1 and LATS2 were 63.66% and 71.5%, respectively, in 88 astrocytomas compared to 10 non-tumoral brain samples presenting an unmethylated promoter profile [61].